Dalin Tzu Chi Hospital
Dalin, Chiayi, 622, Taiwan
NCT Number: NCT06875115
Sixty patients were randomly assigned to either the experimental group (n=30) receiving laser acupuncture or the control group (n=30) receiving sham laser acupuncture. Treatment sessions were conducted during dialysis sessions. The experimental group received laser acupuncture at Xuehai, Quchi, and Bai Chongwo acupoints three times per week for four weeks. The control group received sham laser acupuncture at the same acupoints. The 5-D Pruritus Scale and DLQI were used to assess pruritus severity before and after the intervention.
Looking for future studies?
Notify Me20 year–90 year
All sexes
Interventional
Not applicable
Dalin, Chiayi, 622, Taiwan
The subjects were divided into two groups to investigate whether laser acupuncture can improve uremic pruritus.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
laser acupuncture on acupoints
Time frame: A 4-week timeframe from enrollment to treatment completion.
The severity of uremic pruritus was assessed using the 5-D Itch Scale, a validated instrument that measures itch duration, degree, direction, disability, and distribution. The total score ranges from 5 to 25, with higher scores indicating worse pruritus. Measurements were taken at baseline and at week 4 after completion of the laser acupuncture or sham intervention.
Dalin Tzu Chi General Hospital
Other
Evaluation of the Efficacy of Laser Acupuncture on Uremic Pruritus-Randomized Controlled Trial Double Blind
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05076318
Amino Acid Metabolism, Inborn Errors, Brain Diseases
Aarhus N, Denmark
View Trial DetailsNCT04768309
CKD, Female Urogenital Diseases
Pierre-Bénite, Rhône, France
View Trial DetailsNCT07086430
End Stage Renal Disease on Dialysis, Female Urogenital Diseases
View Trial DetailsNCT05899283
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Beijing, Beijing Municipality, China
View Trial Details